Robert Dreicer

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Effect of Cisplatin and Gemcitabine With or Without Berzosertib in Patients With Advanced Urothelial Carcinoma”.

Effect of Cisplatin and Gemcitabine With or Without Berzosertib in Patients With Advanced Urothelial Carcinoma

JAMA Oncology(2021)10.1001/jamaoncol.2021.3441

N/A

1.6DataRank · unranked

45 citations

Paul Frankel, Amir Mortazavi, Matthew I. Milowsky, Ulka N. Vaishampayan, Mamta Parikh +15 more

Pain and Its Association with Survival for Black and White Individuals with Advanced Prostate Cancer in the United States

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0446

N/A

0.414DataRank · unranked

8 citations

Natalie Slopen, Hannah D. McManus, Karen A. Autio, Alicia K. Morgans, Lawrence McSwain +24 more

Phase 1/2 multiple ascending dose trial of the prostate-specific membrane antigen-targeted antibody drug conjugate MLN2704 in metastatic castration-resistant prostate cancer

UNC Libraries(2020)10.17615/41rk-2070

N/A

0DataRank · unranked

0 citations

Matthew D. Galsky, Iain J. Webb, Jesika Petruck, Michael J. Morris, Robert Dreicer +7 more

A randomized phase II study comparing cisplatin and gemcitabine with or without berzosertib in patients with advanced urothelial carcinoma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.4507

N/A

0DataRank · unranked

1 citations

Amir Mortazavi, Matthew I. Milowsky, Ulka N. Vaishampayan, Mamta Parikh, Yung Lyou +15 more

CD46 targeted 212 Pb alpha particle radioimmunotherapy for prostate cancer treatment

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.10.14.512321

N/A

0DataRank · unranked

0 citations

Tao Huang, Jun Hua, Qiong Wang, Su Yang, Ping Chen +14 more

CD46 targeted 212Pb alpha particle radioimmunotherapy for prostate cancer treatment

Journal of Experimental & Clinical Cancer Research(2023)10.1186/s13046-023-02636-x

N/A

0DataRank · unranked

40 citations

Tao Huang, Jun Hua, Qiong Wang, Su Yang, Ping Chen +14 more

Quality of life in the year after new diagnosis with advanced prostate cancer for Black and White individuals living in the US

Quality of Life Research(2023)10.1007/s11136-023-03468-0

N/A

0DataRank · unranked

9 citations

Natalie Slopen, Karen A. Autio, Alicia K. Morgans, Lawrence McSwain, Pedro C. Barata +18 more

Data from Molecular Imaging of Prostate Cancer Targeting CD46 Using ImmunoPET

(2023)10.1158/1078-0432.c.6529904

N/A

0DataRank · unranked

0 citations

Jun Li, Jun Hua, Yang Su, Denis Beckford-Vera, Walter Zhao +20 more

HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer

JAMA Oncology(2020)10.1001/jamaoncol.2019.6496

N/A

0DataRank · unranked

75 citations

Christopher J. Sweeney, Nima Almassi, Chad A. Reichard, C.A. Reddy, Hong Li +9 more

Atezolizumab monotherapy for metastatic urothelial carcinoma: final analysis from the phase II IMvigor210 trial

ESMO Open(2024)10.1016/j.esmoop.2024.103972

N/A

0DataRank · unranked

29 citations

M.D. Galsky, Thomas Powles, Daniel P. Petrylak, Joaquim Bellmunt, Y. Loriot +19 more

Molecular Imaging of Prostate Cancer Targeting CD46 Using ImmunoPET

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-3310

N/A

0DataRank · unranked

41 citations

Jun Li, Jun Hua, Su Yang, Denis Beckford-Vera, Walter Zhao +20 more